- Home
- KPTI vs MODD Comparison
KPTI vs MODD Comparison
Compare KPTI & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- MODD
- Stock Information
- Founded
- KPTI 2008
- MODD 1998
- Country
- KPTI United States
- MODD United States
- Employees
- KPTI N/A
- MODD N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- KPTI Health Care
- MODD Health Care
- Exchange
- KPTI Nasdaq
- MODD Nasdaq
- Market Cap
- KPTI 33.6M
- MODD 35.5M
- IPO Year
- KPTI 2013
- MODD N/A
- Fundamental
- Price
- KPTI $4.21
- MODD $0.89
- Analyst Decision
- KPTI Strong Buy
- MODD
- Analyst Count
- KPTI 5
- MODD 0
- Target Price
- KPTI $61.00
- MODD N/A
- AVG Volume (30 Days)
- KPTI 172.5K
- MODD 179.7K
- Earning Date
- KPTI 05-07-2025
- MODD 02-13-2025
- Dividend Yield
- KPTI N/A
- MODD N/A
- EPS Growth
- KPTI N/A
- MODD N/A
- EPS
- KPTI N/A
- MODD N/A
- Revenue
- KPTI $145,237,000.00
- MODD N/A
- Revenue This Year
- KPTI $4.87
- MODD N/A
- Revenue Next Year
- KPTI $16.29
- MODD N/A
- P/E Ratio
- KPTI N/A
- MODD N/A
- Revenue Growth
- KPTI N/A
- MODD N/A
- 52 Week Low
- KPTI $3.51
- MODD $0.68
- 52 Week High
- KPTI $21.30
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- KPTI 37.33
- MODD 43.45
- Support Level
- KPTI $3.83
- MODD $0.78
- Resistance Level
- KPTI $4.36
- MODD $1.04
- Average True Range (ATR)
- KPTI 0.55
- MODD 0.10
- MACD
- KPTI 0.13
- MODD -0.01
- Stochastic Oscillator
- KPTI 25.64
- MODD 27.65
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.